Immatics (IMTX) Interest Expenses (2019 - 2025)
Immatics' (IMTX) quarterly Interest Expenses came in at -$599482.4 in Q4 2025, down 113.95% year-on-year from $4.3 million in Q4 2024, and down 77.44% quarter-over-quarter from -$337856.9 in Q3 2025.
Immatics (IMTX) Interest Expenses (2019 - 2025) Analysis & Trends
Immatics has disclosed Interest Expenses across 7 years of filings, most recently posting -$599482.4 for Q4 2025.
- Interest Expenses for Q4 2025 came in at -$599482.4, down 113.95% year-over-year; the trailing twelve-month figure through Dec 2025 was -$40.7 million (down 284.67% YoY), and the FY2025 annual result was -$41.4 million, down 2834.63% from the prior year.
- Interest Expenses came in at -$599482.4 for Q4 2025 at Immatics, down from -$337856.9 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $4.3 million in Q4 2024 to a low of -$25.8 million in Q2 2025.
- The 5-year median for Interest Expenses is -$1.0 million (2021), against an average of -$3.6 million.
- Across the five-year window, Interest Expenses soared 363.75% in 2021 and plunged 7749.43% in 2025, its largest moves.
- Immatics' Interest Expenses stood at -$2.2 million in 2021, then plunged by 191.1% to -$6.5 million in 2022, then soared by 51.78% to -$3.1 million in 2023, then surged by 237.99% to $4.3 million in 2024, then plunged by 113.95% to -$599482.4 in 2025.
- The last three Interest Expenses figures came in at -$599482.4 (Q4 2025), -$337856.9 (Q3 2025), and -$25.8 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Immatics | 14.67 Bn | 14.67 Bn | - | -599,482.41 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -599,482.41 |
| Dec 31, 2025 | -599,482.41 |
| Sep 30, 2025 | -337,856.92 |
| Sep 30, 2025 | -337,856.92 |
| Jun 30, 2025 | -25.78 Mn |
| Jun 30, 2025 | -25.78 Mn |
| Mar 31, 2025 | -14.03 Mn |
| Mar 31, 2025 | -14.03 Mn |
| Dec 31, 2024 | 4.30 Mn |
| Dec 31, 2024 | 4.30 Mn |
| Sep 30, 2024 | -13.83 Mn |
| Sep 30, 2024 | -13.83 Mn |
| Jun 30, 2024 | -328,450.71 |
| Jun 30, 2024 | -328,450.71 |
| Mar 31, 2024 | -735,466.92 |
| Mar 31, 2024 | -735,466.92 |
| Dec 31, 2023 | -3.11 Mn |
| Dec 31, 2023 | -3.11 Mn |
| Sep 30, 2023 | -1.71 Mn |
| Sep 30, 2023 | -1.71 Mn |